# Study Comparing the Safety and Efficacy of AR-13324 to Latanoprost in Patients With Elevated Intraocular Pressure

> **NCT01731002** · PHASE2 · COMPLETED · sponsor: **Aerie Pharmaceuticals** · enrollment: 224 (actual)

## Conditions studied

- Ocular Hypertension
- Open Angle Glaucoma

## Interventions

- **DRUG:** AR-13324 Ophthalmic Solution 0.01%
- **DRUG:** AR-13324 Ophthalmic Solution 0.02%
- **DRUG:** Latanoprost ophthalmic solution 0.005%

## Key facts

- **NCT ID:** NCT01731002
- **Lead sponsor:** Aerie Pharmaceuticals
- **Sponsor class:** INDUSTRY
- **Phase:** PHASE2
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2012-11
- **Primary completion:** 2013-05
- **Final completion:** 2013-05
- **Target enrollment:** 224 (ACTUAL)
- **Last updated:** 2018-04-17


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT01731002

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT01731002, "Study Comparing the Safety and Efficacy of AR-13324 to Latanoprost in Patients With Elevated Intraocular Pressure". Retrieved via AI Analytics 2026-07-26 from https://api.ai-analytics.org/clinical/NCT01731002. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*